Your browser doesn't support javascript.
loading
Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations.
Matarraz, S; Paiva, B; Díez-Campelo, M; Bárrena, S; Jara-Acevedo, M; Gutiérrez, M L; Sayagués, J M; Sánchez, M-L; Bárcena, P; Garrastazul, M P; Berruezo, M J; Duran, J M; Cerveró, C; García-Erce, J A; Florensa, L; Méndez, G D; Gutierrez, O; Del Cañizo, M C; van Dongen, J J M; San Miguel, J F; Orfao, A.
Afiliação
  • Matarraz S; Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.
  • Paiva B; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.
  • Díez-Campelo M; Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain.
  • Bárrena S; Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.
  • Jara-Acevedo M; Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.
  • Gutiérrez ML; Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.
  • Sayagués JM; Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.
  • Sánchez ML; Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.
  • Bárcena P; Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.
  • Garrastazul MP; Department of Hematology, Hospital Punta Europa, Algeciras, Spain.
  • Berruezo MJ; Department of Hematology, Hospital Punta Europa, Algeciras, Spain.
  • Duran JM; Department of Hematology, Hospital La Línea, Cádiz, Spain.
  • Cerveró C; Department of Hematology, Hospital Virgen de la Luz, Cuenca, Spain.
  • García-Erce JA; Department of Hematology, Hospital San Jorge, Huesca, Spain.
  • Florensa L; Department of Hematology, Hospital del Mar, Barcelona, Spain.
  • Méndez GD; Department of Hematology, Hospital de Jerez, Cádiz, Spain.
  • Gutierrez O; Department of Hematology, Rio Hortega Hospital, Valladolid, Spain.
  • Del Cañizo MC; Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain.
  • van Dongen JJ; Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • San Miguel JF; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.
  • Orfao A; Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.
Leukemia ; 28(8): 1747-50, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24625552
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article